We are delighted to have taken part in Shangai for the CPHI China ! 🇨🇳
This participation allowed us to meet the industry and connect with customers and partners from the Asian pharmaceutical supply chain, to discuss the heartening future of Hyaluronic Acid (HA) and another biopolymer, Polynucleotides.
Thanks to everyone who visited our booth and made this event a success.
Looking forward to the next edition !
To see our most recent news,
![](https://htlbiotech.com/wp-content/uploads/2023/08/partner-1.jpg)
Read more
news from us
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 13, 2024
Discover our Quality Policy
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.
-
Articles June 5, 2024
National Bioproduction and Biomedicine Day (TVR report)
On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javené site for an exclusive report.